Elsevier

Medicine

Volume 42, Issue 6, June 2014, Pages 327-332
Medicine

Bacterial infections I
Chlamydia trachomatis and non-gonococcal urethritis

https://doi.org/10.1016/j.mpmed.2014.03.001Get rights and content

Abstract

Chlamydia is a common sexually transmitted infection (STI) in young people. It is often asymptomatic, but untreated infection can have significant long-term complications that may present to non-sexual health specialities. These include pelvic inflammatory disease (PID) and infertility in women. Current diagnostic techniques are sensitive and highly specific and are approved for patient-taken samples. This means non-specialist settings are well placed to diagnose and treat chlamydia in individuals from high-risk groups who may not access hospital-based healthcare services. The English National Chlamydia Screening Programme (NCSP) aims for all sexually active young men and women under the age of 25 to be aware of chlamydia and its effects, and have access to services providing screening, prevention and treatment, but there remains debate about its cost-effectiveness. Testing for chlamydia should be used as an opportunity to screen for other STIs including gonorrhoea, HIV and syphilis where indicated and also as a chance to offer advice for those engaging in high-risk sexual behaviour. Non-gonococcal urethritis is an important cause of urethral discharge and dysuria in men and is usually sexually transmitted. However, it can occur in stable relationships and in 30% no micro-organism is detected. Diagnosis and treatment are best undertaken in a specialist sexual health centre, although management is possible in a community setting. There is debate about the efficacy of current recommended treatments and national guidelines should be consulted for up-to-date antibiotic regimens.

Section snippets

Chlamydia trachomatis

C. trachomatis is the most common bacterial sexually transmitted micro-organism in the developed world, causing genital, rectal and ocular disease. Serovars A–C cause trachoma; serovars D–K affect primarily the genital tract but can infect other mucosal surfaces including the conjunctiva, pharynx and rectum.1 Serovars L 1–3 cause lymphogranuloma venereum (LGV). LGV has recently emerged as an important cause of rectal disease in men who have sex with men (MSM). (See Lymphogranuloma venereum

Non-gonococcal urethritis (non-specific urethritis)

The terms non-gonococcal urethritis (NGU) and non-specific urethritis (NSU) describe a similar condition.19 For the purposes of this article, NGU refers only to urethritis in men, with symptoms and/or signs.

References (25)

  • P. Sonnenberg et al.

    Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)

    Lancet

    (2013)
  • P. Horner et al.

    2006 UK National Guideline for the Management of Genital Tract Infection with Chlamydia trachomatis

    (2006)
  • National Chlamydia screening programme

    (2013)
  • Public Health England

    Genital Chlamydia trachomatis tests and diagnoses in young people, 2012

    Health Prot Rep

    (2013)
  • Department of Health

    A framework for sexual health improvement in England

    (2013)
  • National Audit Office et al.

    Young people's sexual health: the National Chlamydia Screening Programme

    (2009)
  • M. Price et al.

    Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model

    Am J Epidemiol

    (2013)
  • P.J. Horner et al.

    C. trachomatis pgp3 antibody prevalence in young women in England, 1993–2010

    PLoS One

    (2013)
  • S. Gottlieb et al.

    Summary: the natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control

    J Infect Dis

    (2010)
  • M.J. Price et al.

    Mixture-of-exponentials models to explain heterogeneity in studies of the duration of Chlamydia trachomatis infection

    Stat Med

    (2013)
  • K. Turner et al.

    Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study

    BMJ

    (2011)
  • D.J. Templeton et al.

    Prevalence, incidence and risk factors for pharyngeal chlamydia in the community based Health in Men (HIM) cohort of homosexual men in Sydney, Australia

    Sex Transm Infect

    (2008)
  • Cited by (0)

    View full text